Prognostic significance of 18F-Fluorodeoxyglucose positron-emission tomography parameters in patients with biliary tract cancers: a meta-analysis

Table 2 Results of meta-analysis of interested outcomes

Outcomes	Cohort count	Case count	HR (95%CI)-Model	P	Heterogeneity		Public bias
Outcomes	Cohort count	Case count	HR (95%CI)-Model	P	I² (%)	P-value	Begg test P	Egger test P
OS
Tumor SUVmax	19	1326	2.07 (1.74–2.46)-fixed	0.000	13.8	0.740	0.400	0.059
TLG	5	202	1.91 (1.26–2.90)-fixed	0.002	0.0	0.484	0.142	0.083
MTV	5	202	2.04 (1.26–3.31)-fixed	0.004	8.6	0.357	0.051	0.257
ΔSUVmax	3	136	1.26 (1.06–1.50)-fixed	0.008	26.6	0.256	0.940	0.602
LN SUVmax	2	301	1.49 (0.83–2.68)-fixed	0.178	0.0	0.643	0.317	–
DFS
Tumor SUVmax	8	458	2.28 (1.53–3.41)-random	0.000	69.5	0.005	0.881	0.068
TLG	2	49	4.34(1.42–13.27)-fixed	0.010	0.0	0.660	0.317	–
MTV	2	49	3.88(1.25–12.09)-random	0.019	52.1	0.148	0.317	–
PFS
ΔSUVmax	2	110	1.96(0.82–4.72)-random	0.280	80.5	0.024	0.317	–

ISSN: 1471-2342